Quantum Technology joins hands with Ancient Science to combat the Pandemic

Across the world, currently, a lot of research is happening on Pharmaceuticals and Medicine, especially in context with the current pandemic situation. A breakthrough

in this, is the discovery of the use of Quantum Technology in finding the solution to the global threat.

Kepler Healthcare, an award-winning pharmaceutical company, to contribute towards management of the current pandemic, has come up with two unique products called AAYOG

Advance and AAYOG Protect. Now, these products are essentially a combination of the knowledge of ancient Ayurveda with principles of Quantum Electro-Mechanical Physics.

According to Mr. Harpal Vala, Founder - Director of Kepler Healthcare, “When it came to critical medical solutions, we are mostly dependent on the Western World. The

idea of AAYOG was our step towards an ‘Aatmanirbhar Bharat’. The products are a combination of 21 essential oils in varied proportions along with water mentioning no use of metals.” The company has already applied for a patent for the process used in the formulation.

AAYOG Advance is the fusion of essential oils with Quantum Science. Here, each quantum particle is highly ‘target-specific’ and hence potent. It has the capacity to

enter the virus and break it, hence it is called a ‘Potent Viral Load Reducer’. Further, it reduces the proliferation by making the surrounding alkaline. It not only kills the virus but also upregulates innate immunity.

Their second variant, AAYOG Protect is for protection from the pandemic that stops penetration and replication of virus. This can be highly effective in the prevention

of current pandemic.

The developed formulation was to be tested on affected pandemic patients. So, to authenticate the findings, the formulation went for a Clinical Trial. Upon the approval

from the CTRI, the clinical trial was conducted at SVP Hospital Ahmedabad, which is one of the major hospitals for the treatment.

For the Clinical Trial, 60 patients affected by the COVID-19 completed the trial. Out of which 30 patients were given the Standard of Care (SOC, as per ICMR Guidelines)

and 30 patients were given SOC + AAYOG Advance. Clearly the ones with AAYOG Advance showed 100% recovery, which was 15.38% more in case of SOC. The reduction in viral load (inferred by increase in CT value of E gene and RDRP gene) in case of AAYOG Advance

treatment was found statistically significant (p<0.01) as compared to SOC alone. The AAYOG Advance was found to be 100% safe without any side effects.

The second Clinical Trial for AAYOG Advance is going on. “Our success so far is a result of the entire team's hard work and passion. We already have innumerable testimonials.

I am sure, AAYOG Advance and AAYOG Protect will become a blessing for the nation”, says Mr. Harpal Vala.

It is quite encouraging that numerous Doctors have put faith in these products and have monitored positive results themselves. “Heard about miracles in medical history

but seen for the first time with AAYOG Advance in patients with SARS/ARDS. It is a boon for humanity in such crises. Thanks to Kepler Healthcare,” says Dr. Aseem Mehta, MD, Nagpur.

MD Physician from Ahmedabad Dr. Nalin Gheewala says, “I have used AAYOG Advance in many of my patients suffering from the pandemic and AAYOG Protect in many family contacts.

I have found results encouraging in almost all the patients in symptoms and viral load reduction. It has practically no side effects. I feel its wonderful medicine in this pandemic and cost effective. Patients can remain at home and take treatment.

 

AAYOG Advance - as an add-on Medication to SOC, helps a lot - in mild to moderate patients. Clinical observation suggests that now fewer patients require hospitalisation and experience less of hypoxia. According to Dr. Gajanand Mohata, M.D. Physician, Ahmedabad

“Kepler Healthcare has a strong distribution network which will play a key-role to combat the pandemic. The company is committed to make their products available to every corner of India. Altogether, they aim to treat or protect more than 2 crore Indians.” – say Mr. Rakesh Shah, Director of Kepler Healthcare

It is exciting to know that the company's vision is to reach out to maximum numbers of patients and contribute towards their relief rather than its commercial aspect.

Kepler Healthcare has led by example and we sincerely hope that it continues to do such work and that, more such companies come forward to invest resources and contribute to a healthy nation.